Connect with us
Faes Farma forecasts a double-digit growth in Latin America and plans to expand its medical visit, animal nutrition, and health businesses. The Spanish pharmaceutical company aims...
Cure51 secured funding in a round led by Sofinnova Partners, joined by Hitachi Ventures, Xavier Niel, and others. The company aims to investigate molecular processes enabling...
Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...
Europacific Growth Fund, legal owner of Grifols shares, lent over 100 million euros worth of shares, reducing its ownership from 3.4% to 3.2%. Capital Research and...
MDMA became famous in the 80s as a party drug under the names Ecstasy or Molly - complete with abuse, damage, and deaths. As a result,...
AstraZeneca Spain's president, Rick R. Suárez, announced a €1.3 billion investment in Catalonia until 2027, exceeding previous plans by €500 million. They aim to employ 2,000...
BlackRock, Capital Research and Management Company, and Jefferies Financial Group lend over 170 million euros in Grifols shares. Specifically, BlackRock, which has a 4.3% stake in...
Almirall has acquired exclusive rights to Eloxx Pharmaceuticals' ZKN-013, a potentially promising treatment for rare dermatological diseases. Almirall gains global development and commercialization rights, paying Eloxx...
AstraZeneca and Wivi Vision were awarded the Bioèxit Prize during the Nit event organized by CataloniaBio&HealthTech. AstraZeneca was recognized for establishing its global hub in Barcelona,...
In the Spanish biotech sector, 60% of employees are women, yet only 37% of leadership positions in companies are held by women, according to a report...
 |
|
 |  |
 |
|